Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting.
Fougerousse AC, Maccari F, Beauchet A, Parier J, Boulard C, Becherel PA, Quiles-Tsimaratos N, Le Guyadec T, Thomas-Beaulieu D, Halioua B, Begon E, Bastien M, Perrot JL, Pallure V, Bilan P, Steff M, Pfister P, Vermersch-Langlin A, Boyé T, Mery-Bossard L, Maillard H, Kemula M, Girard C, Poiraud C, Monfort JB, Kupfer-Bessaguet I, Perrussel M, Lons-Danic D, Sultan N, Lorier E, Zeitoun M, Wagner L, Gabison G, Mahé E; GEM Resopso. Fougerousse AC, et al. Among authors: thomas beaulieu d. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e476-e478. doi: 10.1111/jdv.15804. Epub 2019 Jul 30. J Eur Acad Dermatol Venereol. 2019. PMID: 31310364 No abstract available.
Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis.
Phan C, Sigal ML, Estève E, Reguiai Z, Barthélémy H, Beneton N, Maccari F, Lahfa M, Thomas-Beaulieu D, Le Guyadec T, Vermersch-Langlin A, Mery-Bossard L, Pallure V, Kemula M, Labeille B, Beauchet A, Mahé E; GEM RESOPSO. Phan C, et al. Among authors: thomas beaulieu d. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):78-82. doi: 10.1111/jdv.12850. Epub 2014 Nov 11. J Eur Acad Dermatol Venereol. 2016. PMID: 25389080
Tattoo complications in treated and non-treated psoriatic patients.
Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly-Auvray D, Ruer-Mulard M, Boulard C, Jacobzone C, Thomas-Beaulieu D, Pourchot D, Méry-Bossard L, Chaby G, Girard C, Duval-Modeste AB, Vermersch-Langlin A, Delaunay J, Marc S, Kemula M, Steff M, Bilan P, Liégeon AL, Aubert H, Solyga B, Kluger N, Mahé E; GEM Resopso. Grodner C, et al. Among authors: thomas beaulieu d. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):888-896. doi: 10.1111/jdv.15975. Epub 2019 Oct 24. J Eur Acad Dermatol Venereol. 2020. PMID: 31568596
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Chaby G, Bastien M, Begon E, Samimi M, Prignano F, Beauchet A, Mahé E; GEM Resopso. Phan C, et al. Among authors: thomas beaulieu d. Drugs Aging. 2020 Sep;37(9):657-663. doi: 10.1007/s40266-020-00781-y. Drugs Aging. 2020. PMID: 32696432
[Psoriatic patients: Analysis of patients dissatisfied with their management].
Mahé E, Maccari F, Beauchet A, Quiles-Tsimaratos N, Beneton N, Parier J, Barthelemy H, Goujon-Henry C, Chaby G, Thomas-Beaulieu D, Géner G, Wagner L, Pallure V, Devaux S, Vermersch-Langlin A, Pfister P, Jégou J, Livideanu C, Sigal ML; pour le GEM Resopso. Mahé E, et al. Among authors: thomas beaulieu d. Ann Dermatol Venereol. 2017 Aug-Sep;144(8-9):497-507. doi: 10.1016/j.annder.2017.03.025. Epub 2017 Jun 16. Ann Dermatol Venereol. 2017. PMID: 28624255 French.
Successful treatment with ixekizumab of lower-limb linear psoriasis in a child.
Pourchot D, Mery-Bossard L, Petitjean B, Mahé E, Thomas-Beaulieu D. Pourchot D, et al. Among authors: thomas beaulieu d. Ann Dermatol Venereol. 2022 Sep;149(3):216-218. doi: 10.1016/j.annder.2022.02.003. Epub 2022 Mar 10. Ann Dermatol Venereol. 2022. PMID: 35282894 No abstract available.
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Perrot JL, Ruer-Mulard M, Bastien M, Begon E, Samimi M, Jacobzone C, Quiles-Tsimaratos N, Descamps V, Steff M, Bilan P, Vermersch-Langlin A, Kemula M, Amazan E, Kupfer-Bessaguet I, Cottencin AC, Prignano F, Livideanu B, Gottlieb J, Beauchet A, Mahé E; the Groupe d’Etudes Multicentriques (GEM) RESOPSO. Phan C, et al. Among authors: thomas beaulieu d. Acta Derm Venereol. 2020 Nov 4;100(18):adv00316. doi: 10.2340/00015555-3678. Acta Derm Venereol. 2020. PMID: 33111960 Free PMC article.
Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years.
Descamps V, Mahé E, Maccari F, Begon E, Barthelemy H, Reguiai Z, Bénéton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Thomas-Beaulieu D, Avenel-Audran M, Goujon-Henry C, Sigal ML, Ezzedine K, Beauchet A; Groupe d’Etudes Multicentriques RESOPSO. Descamps V, et al. Eur J Dermatol. 2014 May-Jun;24(3):356-60. doi: 10.1684/ejd.2014.2346. Eur J Dermatol. 2014. PMID: 24979347
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.
Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases. Plaquevent M, et al. Among authors: thomas beaulieu d. J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10. J Invest Dermatol. 2019. PMID: 30543900 Free article.
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T, Arnulf B, Bouaziz JD, Livideanu CB, Osio A, Servy A, Cribier B, Sassolas B, Jachiet M, Michel L, Aucouturier P, Lipsker D, Frances C, Sbidian E, Rybojad M, Descamps V, D'Incan M, Humbert P, Beylot-Barry M, Passeron T, de Moreuil C, Taha RY, Hermine O, Dupuy A, Barbarot S, Debarbieux S, Carpentier O, Brault F, Schmutz JL, Thomas-Beaulieu D, Modiano P, Zarnitsky C, Lifermann F, Baubion E, Limal N, Le Bras F, Le Moigne M, Tauber M, Talbot A, Prud'homme R, Peltier S, De Masson A, Battistella M, Bagot M, Mékinian A, Fain O. Mahévas T, et al. Among authors: thomas beaulieu d. Blood. 2020 Apr 2;135(14):1101-1110. doi: 10.1182/blood.2019002300. Blood. 2020. PMID: 32027747 Free article.
11 results